Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$1.08M Buy
136,172
+7,675
+6% +$57.6K ﹤0.01% 3505
2014
Q2
$1.03M Buy
128,497
+37,410
+41% +$279K ﹤0.01% 3509
2014
Q1
$783K Buy
91,087
+14,329
+19% +$132K ﹤0.01% 3743
2013
Q4
$749K Buy
76,758
+2,040
+3% +$18.5K ﹤0.01% 3865
2013
Q3
$631K Buy
74,718
+21,067
+39% +$171K ﹤0.01% 3868
2013
Q2
$390K Buy
+53,651
New +$312K ﹤0.01% 4338

Other funds holding ACLS

UBS's ACLS Position: Q3 2014 in Review

UBS increased its Axcelis (ACLS) stake by 6% in Q3 2014, buying an estimated $57.6K and bringing the position to 136,172 shares worth $1.08M. The position accounts for ﹤0.01% of the portfolio, ranked #3505.

UBS first reported a position in ACLS in Q2 2013 and has held it in 6 quarters since. 88 funds tracked by Wall St. Rank hold ACLS as of Q3 2014.

  • UBS held 136,172 shares of Axcelis worth $1.08M as of Q3 2014.
  • UBS bought 7,675 Axcelis shares in Q3 2014, an estimated $57.6K.
  • Axcelis made up ﹤0.01% of UBS's portfolio in Q3 2014, its #3505 holding.
  • UBS first reported a position in Axcelis in Q2 2013 and has held it in 6 quarters since.
  • 88 funds tracked by Wall St. Rank held Axcelis as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.